Author

Madison Leigh Ellis

Emory UniversityORCID 0000-0002-0325-5477Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 3 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Mehul S. SuthariD· 4 shared Ansa A. Malik· 2 shared Daniel C. DouekiD· 2 shared Lilin LaiiD· 2 shared Sucheta GodboleiD· 2 shared Alberto MorenoiD· 1 shared Alex SigaliD· 1 shared Amanda MetziD· 1 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

Mehul S. SutharORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 28, 2026

Wobble Vaccines: Complex Vaccine Antigen Pools Promote Increased Antibody Breadth and Cross-Strain Viral Targeting in SARS-CoV-2

Peter R. McIlroy, Wendy M. Zinzow-Kramer, Madison Leigh Ellis…·Matthew Charles Woodruff

DOI 10.64898/2026.07.01.735277

experimental assaydrug response / drug discovery

𝕏 PostBluesky

ImmunologybioRxivPreprintAug 8, 2024

Eosinophils protect against SARS-CoV-2 following a vaccine breakthrough infection

Kathryn M. Moore, Stephanie L. Foster, Meenakshi Kar…·Mehul S. Suthar

The paper shows that eosinophils protect against SARS-CoV-2 in vaccinated mice during breakthrough infections by reducing viral burden and limiting dissemination.

DOI 10.1101/2024.08.08.607190

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 3, 2024

XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants

Shilpi Jain, Sanjeev Kumar, Lilin Lai…·Mehul S. Suthar

The paper evaluates the effectiveness of an XBB.1.5 monovalent booster vaccine, showing improved antibody binding and neutralization against SARS-CoV-2 Omicron variants.

12 citations

humanproteomics

𝕏 PostBluesky

BioinformaticsbioRxivPreprintSep 27, 2023

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera

Barbara Mühlemann, Samuel Wilks, Lauren Baracco…·Derek J. Smith

The paper compares SARS-CoV-2 antigenicity across assays and in human and animal model sera, finding similar immunodominance patterns and antigenic maps but differences in titer magnitude and assay-specific fold change.

4 citations

𝕏 PostBluesky